Literature DB >> 21719595

Impact of an interchange program to support use of insulin pens.

Leah G Ward1, Sara S Aton.   

Abstract

PURPOSE: The impact of a hospital initiative to reduce staff needle-stick injuries and overall insulin costs by switching from use of insulin vials to use of insulin pens for treatment of inpatients was evaluated.
METHODS: An interchange program entailing a switch from vial-and-syringe insulin administration to insulin delivery via prefilled injector pens was implemented at a specialty clinic and hospital. Patient and employee incident reports were reviewed to identify insulin-related staff needle-stick injuries and to assess patient safety indicators during six-month periods before and after implementation of the interchange. Pharmaceutical purchasing data were used to compare total insulin costs for the two periods.
RESULTS: In the six months after implementation of the interchange program, nurses treated 2,084 patients with subcutaneous insulin products; there was one staff needle-stick injury, compared with five injuries during the designated preimplementation period (2,118 patients treated). During the six months after the switch to insulin injector pens, there were four reports of wrong-drug errors (three errors during dispensing and one error during administration to the patient), all involving insulin detemir and insulin aspart pens; in addition, there was one reported wrong-time error associated with a sliding-scale order for insulin aspart. Total insulin product costs for the preimplementation and postimplementation periods were $124,181 and $60,655, respectively.
CONCLUSION: Using an interchange program to support the use of insulin pens at a specialty clinic and hospital provided increased staff safety and cost savings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719595     DOI: 10.2146/ajhp100535

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  Overview of insulin and non-insulin delivery devices in the treatment of diabetes.

Authors:  Michele Pisano
Journal:  P T       Date:  2014-12

2.  Review of insulin therapy and pen use in hospitalized patients.

Authors:  Estella M Davis; Pamela A Foral; Ryan B Dull; April N Smith
Journal:  Hosp Pharm       Date:  2013-05

3.  Insulin vials vs. insulin cartridges: Further cost considerations.

Authors:  Mohammad G Al-Sharayri; Tariq M Alsabrah; Tareq M Aljbori; Ala'a Eddeen K Abu-Rumman
Journal:  Saudi Pharm J       Date:  2012-08-26       Impact factor: 4.330

4.  Economic Impact of Converting from Pen and 10-mL Vial to 3-mL Vial for Insulin Delivery in a Hospital Setting.

Authors:  Eby Elizabeth; Lee Smolen; Amber Pitts; Linda A Krueger; Doneen Grimm
Journal:  Hosp Pharm       Date:  2014-12

5.  Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis.

Authors:  Giovanni Veronesi; Carmine S Poerio; Alessandra Braus; Maurizio Destro; Lavinia Gilberti; Giovanni Meroni; Estella M Davis; Antonio C Bossi
Journal:  Clin Diabetes Endocrinol       Date:  2015-11-09

6.  Dosing Accuracy of Insulin Aspart FlexPens After Transport Through the Pneumatic Tube System.

Authors:  Leah G Ward; Michael G Heckman; Amy I Warren; Kimberly Tran
Journal:  Hosp Pharm       Date:  2013-01

7.  Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitations.

Authors:  Bruce Freundlich; Alan Kivitz; Jonathan S Jaffe
Journal:  J Clin Rheumatol       Date:  2014-08       Impact factor: 3.517

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.